Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy.

[1]  M. Yliperttula,et al.  Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  S. Chirachanchai,et al.  Chitosan core-corona nanospheres: A convenient material to tailor pH and solvent responsive magnetic nanoparticles , 2013 .

[3]  Chengwen Sun,et al.  Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Xia Cao,et al.  Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  Y. Assaraf,et al.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[6]  Yuquan Wei,et al.  A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells. , 2011, International journal of pharmaceutics.

[7]  R. Zeineldin,et al.  Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. , 2011, Gynecologic oncology.

[8]  V. Pillay,et al.  Investigating the Effect of Polymeric Approaches on Circulation Time and Physical Properties of Nanobubbles , 2011, Pharmaceutical Research.

[9]  C. Mohanty,et al.  The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. , 2010, Biomaterials.

[10]  R. Gurny,et al.  Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Y. Zhan,et al.  Degradable poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[12]  R. Agarwal,et al.  Multitargeted therapy of cancer by silymarin. , 2008, Cancer letters.

[13]  L. Hartmann,et al.  Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer , 2007, Journal of cellular biochemistry.

[14]  M. Kahlenberg,et al.  Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. , 2007, The Journal of surgical research.

[15]  Kyung-Ja Cho,et al.  In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. , 2007, Biomaterials.

[16]  G. Scambia,et al.  Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations. , 2006, European journal of cancer.

[17]  Marie Joseph,et al.  Gene expression signature with independent prognostic significance in epithelial ovarian cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P Couvreur,et al.  Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  A. Riva,et al.  Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer. , 2003, European journal of cancer.

[20]  Vijay Kumar,et al.  Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  J. Hadgraft,et al.  The effect of the nature of H-bonding groups on diffusion through PDMS membranes saturated with octanol and toluene. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  R. Agarwal,et al.  Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. , 1999, Cancer letters.

[23]  Keliang Liu,et al.  Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. , 2011, Biomaterials.